Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use
Zach Walsh, Peter S. Hendricks, Stephanie D. Smith, David S. Kosson, Michelle S. Thiessen, Philippe Lucas, Marc T Swogger
Journal of Psychopharmacology April 19, 2016 DOI: 10.1177/0269881116642538 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Prospective cohort study Peer reviewed |
|---|---|
| Sample size | 302 |
| Population | Inmates at a US county jail |
| Keywords | Hallucinogen Poison control Psychopathology Injury prevention Suicide prevention Domestic violence Clinical psychology Medical emergency |
| Citations | 63 |
| Key findings | Hallucinogen use predicted reduced arrest for intimate partner violence. |
Abstract
Evidence suggests that hallucinogens may have therapeutic potential for addressing a variety of problem behaviors related to the externalizing spectrum of psychopathology, such as substance misuse and criminality. Intimate partner violence (IPV) is a prevalent form of criminal violence that is related to externalizing pathology. However, the association between hallucinogen use and IPV has not been comprehensively examined. In this prospective study, we examined the association between IPV and naturalistic hallucinogen use among 302 inmates at a US county jail. Cox regression analyses indicated that hallucinogen use predicted reduced arrest for IPV independently (β=-0.54, SE=0.20, χ(2)=7.19, exp(B)=0.58, p<0.01) and after accounting for covariates (β=-0.48, SE=0.23, χ(2)=4.44, exp(B)=0.62, p<0.05). These results add to a growing literature suggesting distinct therapeutic potential for hallucinogens to assist in the attenuation of problematic behavior.
Citations in the library
Cited by 49
- Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. Pharmacology & Therapeutics May 1, 2019
- The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act Neuropharmacology June 5, 2018
- Psychiatry & the psychedelic drugs. Past, present & future. Neuropharmacology December 25, 2017
- The Therapeutic Potential of Psilocybin Molecules May 15, 2021
- Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions International Review of Psychiatry July 4, 2018
and 44 more in the library
Cites 24
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study Journal of Psychopharmacology January 13, 2015
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. Psychopharmacology December 1, 2011
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction Journal of Psychopharmacology September 11, 2014
and 19 more in the library